Related Experiment Video
Updated: May 14, 2026

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
Published on: February 21, 2018
ELANE mutations in cyclic and severe congenital neutropenia: genetics and pathophysiology
Marshall S Horwitz1, Seth J Corey, H Leighton Grimes
1Department of Pathology, University of Washington School of Medicine, 850 Republican Street, Seattle, WA 98109, USA. horwitz@uw.edu
Insights
Hereditary neutropenia, including cyclic (CN) and severe congenital (SCN) forms, involves neutrophil count disorders. Mutations in ELANE and CSF3R genes offer insights into the pathogenesis of these conditions.
Area of Science:
- Hematology
- Genetics
- Molecular Biology
Background:
- Hereditary neutropenia encompasses two primary forms: cyclic neutropenia (CN) and severe congenital neutropenia (SCN).
- CN is characterized by periodic fluctuations in neutrophil counts, while SCN presents as static neutropenia with bone marrow maturation arrest.
- Genetic underpinnings are crucial, with mutations in ELANE and CSF3R playing significant roles in disease development.
Purpose of the Study:
- To elucidate the genetic basis of hereditary neutropenia.
- To explore the pathogenic mechanisms driven by specific gene mutations.
- To provide insights into the molecular pathways underlying neutropenia.
Main Methods:
- Review of genetic mutations associated with CN and SCN.
- Analysis of gene structures, including ELANE and CSF3R.
- Discussion of current hypotheses regarding molecular pathogenesis.
Main Results:
- Cyclic neutropenia is linked to heterozygous mutations in the ELANE gene.
- Severe congenital neutropenia is genetically heterogeneous, frequently involving ELANE mutations and sometimes somatic mutations in CSF3R.
- Specific mutations provide critical clues to the pathogenesis of neutropenia.
Conclusions:
- Mutations in ELANE are a common cause of both CN and SCN.
- Acquisition of somatic CSF3R mutations is observed in SCN, distinguishing it from CN.
- Understanding these genetic mutations is key to deciphering the molecular mechanisms of hereditary neutropenia.
Abstract:
The 2 main forms of hereditary neutropenia are cyclic (CN) and severe congenital (SCN) neutropenia. CN is an autosomal dominant disorder in which neutrophil counts fluctuate with 21-day periodicity. SCN consists of static neutropenia, with promyelocytic maturation arrest in the bone marrow. Unlike CN, SCN displays frequent acquisition of somatic mutations in the gene CSF3R. CN is caused by heterozygous mutations in the gene ELANE, encoding neutrophil elastase. SCN is genetically heterogeneous but is most frequently associated with ELANE mutations. We discuss how the mutations provide clues into the pathogenesis of neutropenia and describe current hypotheses for its molecular mechanisms.
Related Concept Videos
Mutations
Smooth Endoplasmic Reticulum
The ER provides optimal conditions for synthesizing steroid hormones and lipids, such as phospholipids and triglycerides. Traditionally, lipid metabolism was considered to be a smooth ER function. However, there is no direct evidence to prove that rough ER is completely excluded from lipid...
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
ATP Synthase: Structure
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life

